Global Nervous System Medications Market Growth 2026-2032
The global Nervous System Medications market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Nervous System Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nervous System Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nervous System Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nervous System Medications players cover Pfizer, Teva, Novartis, AstraZeneca, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Nervous System Medications Industry Forecast” looks at past sales and reviews total world Nervous System Medications sales in 2025, providing a comprehensive analysis by region and market sector of projected Nervous System Medications sales for 2026 through 2032. With Nervous System Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nervous System Medications industry.
This Insight Report provides a comprehensive analysis of the global Nervous System Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nervous System Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nervous System Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nervous System Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nervous System Medications.
This report presents a comprehensive overview, market shares, and growth opportunities of Nervous System Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Nervous System Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nervous System Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nervous System Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nervous System Medications players cover Pfizer, Teva, Novartis, AstraZeneca, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Nervous System Medications Industry Forecast” looks at past sales and reviews total world Nervous System Medications sales in 2025, providing a comprehensive analysis by region and market sector of projected Nervous System Medications sales for 2026 through 2032. With Nervous System Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nervous System Medications industry.
This Insight Report provides a comprehensive analysis of the global Nervous System Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nervous System Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nervous System Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nervous System Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nervous System Medications.
This report presents a comprehensive overview, market shares, and growth opportunities of Nervous System Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Anesthetic
- Painkiller
- Psychostimulants
- Antiepileptic Drugs
- Anti-Parkinson Drugs
- Others
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva
- Novartis
- AstraZeneca
- Takeda
- Johnson & Johnson
- EliLilly
- Otsuka
- Merck
- Yangtze River Pharmaceutical
- Humanwell Healthcare
- CSPC-NBP Pharmaceutical
- Nhwa Pharmaceutical
- Qilu Pharma
- What is the 10-year outlook for the global Nervous System Medications market?
- What factors are driving Nervous System Medications market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Nervous System Medications market opportunities vary by end market size?
- How does Nervous System Medications break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nervous System Medications Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nervous System Medications by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nervous System Medications by Country/Region, 2021, 2025 & 2032
2.2 Nervous System Medications Segment by Type
2.2.1 Anesthetic
2.2.2 Painkiller
2.2.3 Psychostimulants
2.2.4 Antiepileptic Drugs
2.2.5 Anti-Parkinson Drugs
2.2.6 Others
2.2.7 Nervous System Medications Sales by Type
2.2.7.1 Global Nervous System Medications Sales Market Share by Type (2021-2026)
2.2.7.2 Global Nervous System Medications Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Nervous System Medications Sale Price by Type (2021-2026)
2.3 Nervous System Medications Segment by Application
2.3.1 Hospital Pharmacy
2.3.2 Retail Pharmacy
2.3.3 Online Pharmacy
2.3.4 Nervous System Medications Sales by Application
2.3.4.1 Global Nervous System Medications Sale Market Share by Application (2021-2026)
2.3.4.2 Global Nervous System Medications Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Nervous System Medications Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nervous System Medications Breakdown Data by Company
3.1.1 Global Nervous System Medications Annual Sales by Company (2021-2026)
3.1.2 Global Nervous System Medications Sales Market Share by Company (2021-2026)
3.2 Global Nervous System Medications Annual Revenue by Company (2021-2026)
3.2.1 Global Nervous System Medications Revenue by Company (2021-2026)
3.2.2 Global Nervous System Medications Revenue Market Share by Company (2021-2026)
3.3 Global Nervous System Medications Sale Price by Company
3.4 Key Manufacturers Nervous System Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nervous System Medications Product Location Distribution
3.4.2 Players Nervous System Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NERVOUS SYSTEM MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Nervous System Medications Market Size by Geographic Region (2021-2026)
4.1.1 Global Nervous System Medications Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nervous System Medications Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nervous System Medications Market Size by Country/Region (2021-2026)
4.2.1 Global Nervous System Medications Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nervous System Medications Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nervous System Medications Sales Growth
4.4 APAC Nervous System Medications Sales Growth
4.5 Europe Nervous System Medications Sales Growth
4.6 Middle East & Africa Nervous System Medications Sales Growth
5 AMERICAS
5.1 Americas Nervous System Medications Sales by Country
5.1.1 Americas Nervous System Medications Sales by Country (2021-2026)
5.1.2 Americas Nervous System Medications Revenue by Country (2021-2026)
5.2 Americas Nervous System Medications Sales by Type (2021-2026)
5.3 Americas Nervous System Medications Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nervous System Medications Sales by Region
6.1.1 APAC Nervous System Medications Sales by Region (2021-2026)
6.1.2 APAC Nervous System Medications Revenue by Region (2021-2026)
6.2 APAC Nervous System Medications Sales by Type (2021-2026)
6.3 APAC Nervous System Medications Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nervous System Medications by Country
7.1.1 Europe Nervous System Medications Sales by Country (2021-2026)
7.1.2 Europe Nervous System Medications Revenue by Country (2021-2026)
7.2 Europe Nervous System Medications Sales by Type (2021-2026)
7.3 Europe Nervous System Medications Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nervous System Medications by Country
8.1.1 Middle East & Africa Nervous System Medications Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nervous System Medications Revenue by Country (2021-2026)
8.2 Middle East & Africa Nervous System Medications Sales by Type (2021-2026)
8.3 Middle East & Africa Nervous System Medications Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nervous System Medications
10.3 Manufacturing Process Analysis of Nervous System Medications
10.4 Industry Chain Structure of Nervous System Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nervous System Medications Distributors
11.3 Nervous System Medications Customer
12 WORLD FORECAST REVIEW FOR NERVOUS SYSTEM MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Nervous System Medications Market Size Forecast by Region
12.1.1 Global Nervous System Medications Forecast by Region (2027-2032)
12.1.2 Global Nervous System Medications Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nervous System Medications Forecast by Type (2027-2032)
12.7 Global Nervous System Medications Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Nervous System Medications Product Portfolios and Specifications
13.1.3 Pfizer Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Nervous System Medications Product Portfolios and Specifications
13.2.3 Teva Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Nervous System Medications Product Portfolios and Specifications
13.3.3 Novartis Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Nervous System Medications Product Portfolios and Specifications
13.4.3 AstraZeneca Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Nervous System Medications Product Portfolios and Specifications
13.5.3 Takeda Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Nervous System Medications Product Portfolios and Specifications
13.6.3 Johnson & Johnson Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 EliLilly
13.7.1 EliLilly Company Information
13.7.2 EliLilly Nervous System Medications Product Portfolios and Specifications
13.7.3 EliLilly Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 EliLilly Main Business Overview
13.7.5 EliLilly Latest Developments
13.8 Otsuka
13.8.1 Otsuka Company Information
13.8.2 Otsuka Nervous System Medications Product Portfolios and Specifications
13.8.3 Otsuka Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Otsuka Main Business Overview
13.8.5 Otsuka Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Nervous System Medications Product Portfolios and Specifications
13.9.3 Merck Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Yangtze River Pharmaceutical
13.10.1 Yangtze River Pharmaceutical Company Information
13.10.2 Yangtze River Pharmaceutical Nervous System Medications Product Portfolios and Specifications
13.10.3 Yangtze River Pharmaceutical Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Yangtze River Pharmaceutical Main Business Overview
13.10.5 Yangtze River Pharmaceutical Latest Developments
13.11 Humanwell Healthcare
13.11.1 Humanwell Healthcare Company Information
13.11.2 Humanwell Healthcare Nervous System Medications Product Portfolios and Specifications
13.11.3 Humanwell Healthcare Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Humanwell Healthcare Main Business Overview
13.11.5 Humanwell Healthcare Latest Developments
13.12 CSPC-NBP Pharmaceutical
13.12.1 CSPC-NBP Pharmaceutical Company Information
13.12.2 CSPC-NBP Pharmaceutical Nervous System Medications Product Portfolios and Specifications
13.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 CSPC-NBP Pharmaceutical Main Business Overview
13.12.5 CSPC-NBP Pharmaceutical Latest Developments
13.13 Nhwa Pharmaceutical
13.13.1 Nhwa Pharmaceutical Company Information
13.13.2 Nhwa Pharmaceutical Nervous System Medications Product Portfolios and Specifications
13.13.3 Nhwa Pharmaceutical Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Nhwa Pharmaceutical Main Business Overview
13.13.5 Nhwa Pharmaceutical Latest Developments
13.14 Qilu Pharma
13.14.1 Qilu Pharma Company Information
13.14.2 Qilu Pharma Nervous System Medications Product Portfolios and Specifications
13.14.3 Qilu Pharma Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Qilu Pharma Main Business Overview
13.14.5 Qilu Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nervous System Medications Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nervous System Medications by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nervous System Medications by Country/Region, 2021, 2025 & 2032
2.2 Nervous System Medications Segment by Type
2.2.1 Anesthetic
2.2.2 Painkiller
2.2.3 Psychostimulants
2.2.4 Antiepileptic Drugs
2.2.5 Anti-Parkinson Drugs
2.2.6 Others
2.2.7 Nervous System Medications Sales by Type
2.2.7.1 Global Nervous System Medications Sales Market Share by Type (2021-2026)
2.2.7.2 Global Nervous System Medications Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Nervous System Medications Sale Price by Type (2021-2026)
2.3 Nervous System Medications Segment by Application
2.3.1 Hospital Pharmacy
2.3.2 Retail Pharmacy
2.3.3 Online Pharmacy
2.3.4 Nervous System Medications Sales by Application
2.3.4.1 Global Nervous System Medications Sale Market Share by Application (2021-2026)
2.3.4.2 Global Nervous System Medications Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Nervous System Medications Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nervous System Medications Breakdown Data by Company
3.1.1 Global Nervous System Medications Annual Sales by Company (2021-2026)
3.1.2 Global Nervous System Medications Sales Market Share by Company (2021-2026)
3.2 Global Nervous System Medications Annual Revenue by Company (2021-2026)
3.2.1 Global Nervous System Medications Revenue by Company (2021-2026)
3.2.2 Global Nervous System Medications Revenue Market Share by Company (2021-2026)
3.3 Global Nervous System Medications Sale Price by Company
3.4 Key Manufacturers Nervous System Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nervous System Medications Product Location Distribution
3.4.2 Players Nervous System Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NERVOUS SYSTEM MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Nervous System Medications Market Size by Geographic Region (2021-2026)
4.1.1 Global Nervous System Medications Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nervous System Medications Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nervous System Medications Market Size by Country/Region (2021-2026)
4.2.1 Global Nervous System Medications Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nervous System Medications Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nervous System Medications Sales Growth
4.4 APAC Nervous System Medications Sales Growth
4.5 Europe Nervous System Medications Sales Growth
4.6 Middle East & Africa Nervous System Medications Sales Growth
5 AMERICAS
5.1 Americas Nervous System Medications Sales by Country
5.1.1 Americas Nervous System Medications Sales by Country (2021-2026)
5.1.2 Americas Nervous System Medications Revenue by Country (2021-2026)
5.2 Americas Nervous System Medications Sales by Type (2021-2026)
5.3 Americas Nervous System Medications Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nervous System Medications Sales by Region
6.1.1 APAC Nervous System Medications Sales by Region (2021-2026)
6.1.2 APAC Nervous System Medications Revenue by Region (2021-2026)
6.2 APAC Nervous System Medications Sales by Type (2021-2026)
6.3 APAC Nervous System Medications Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nervous System Medications by Country
7.1.1 Europe Nervous System Medications Sales by Country (2021-2026)
7.1.2 Europe Nervous System Medications Revenue by Country (2021-2026)
7.2 Europe Nervous System Medications Sales by Type (2021-2026)
7.3 Europe Nervous System Medications Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nervous System Medications by Country
8.1.1 Middle East & Africa Nervous System Medications Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nervous System Medications Revenue by Country (2021-2026)
8.2 Middle East & Africa Nervous System Medications Sales by Type (2021-2026)
8.3 Middle East & Africa Nervous System Medications Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nervous System Medications
10.3 Manufacturing Process Analysis of Nervous System Medications
10.4 Industry Chain Structure of Nervous System Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nervous System Medications Distributors
11.3 Nervous System Medications Customer
12 WORLD FORECAST REVIEW FOR NERVOUS SYSTEM MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Nervous System Medications Market Size Forecast by Region
12.1.1 Global Nervous System Medications Forecast by Region (2027-2032)
12.1.2 Global Nervous System Medications Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nervous System Medications Forecast by Type (2027-2032)
12.7 Global Nervous System Medications Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Nervous System Medications Product Portfolios and Specifications
13.1.3 Pfizer Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Nervous System Medications Product Portfolios and Specifications
13.2.3 Teva Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Nervous System Medications Product Portfolios and Specifications
13.3.3 Novartis Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Nervous System Medications Product Portfolios and Specifications
13.4.3 AstraZeneca Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Nervous System Medications Product Portfolios and Specifications
13.5.3 Takeda Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Nervous System Medications Product Portfolios and Specifications
13.6.3 Johnson & Johnson Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 EliLilly
13.7.1 EliLilly Company Information
13.7.2 EliLilly Nervous System Medications Product Portfolios and Specifications
13.7.3 EliLilly Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 EliLilly Main Business Overview
13.7.5 EliLilly Latest Developments
13.8 Otsuka
13.8.1 Otsuka Company Information
13.8.2 Otsuka Nervous System Medications Product Portfolios and Specifications
13.8.3 Otsuka Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Otsuka Main Business Overview
13.8.5 Otsuka Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Nervous System Medications Product Portfolios and Specifications
13.9.3 Merck Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Yangtze River Pharmaceutical
13.10.1 Yangtze River Pharmaceutical Company Information
13.10.2 Yangtze River Pharmaceutical Nervous System Medications Product Portfolios and Specifications
13.10.3 Yangtze River Pharmaceutical Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Yangtze River Pharmaceutical Main Business Overview
13.10.5 Yangtze River Pharmaceutical Latest Developments
13.11 Humanwell Healthcare
13.11.1 Humanwell Healthcare Company Information
13.11.2 Humanwell Healthcare Nervous System Medications Product Portfolios and Specifications
13.11.3 Humanwell Healthcare Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Humanwell Healthcare Main Business Overview
13.11.5 Humanwell Healthcare Latest Developments
13.12 CSPC-NBP Pharmaceutical
13.12.1 CSPC-NBP Pharmaceutical Company Information
13.12.2 CSPC-NBP Pharmaceutical Nervous System Medications Product Portfolios and Specifications
13.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 CSPC-NBP Pharmaceutical Main Business Overview
13.12.5 CSPC-NBP Pharmaceutical Latest Developments
13.13 Nhwa Pharmaceutical
13.13.1 Nhwa Pharmaceutical Company Information
13.13.2 Nhwa Pharmaceutical Nervous System Medications Product Portfolios and Specifications
13.13.3 Nhwa Pharmaceutical Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Nhwa Pharmaceutical Main Business Overview
13.13.5 Nhwa Pharmaceutical Latest Developments
13.14 Qilu Pharma
13.14.1 Qilu Pharma Company Information
13.14.2 Qilu Pharma Nervous System Medications Product Portfolios and Specifications
13.14.3 Qilu Pharma Nervous System Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Qilu Pharma Main Business Overview
13.14.5 Qilu Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nervous System Medications Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nervous System Medications Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Anesthetic
Table 4. Major Players of Painkiller
Table 5. Major Players of Psychostimulants
Table 6. Major Players of Antiepileptic Drugs
Table 7. Major Players of Anti-Parkinson Drugs
Table 8. Major Players of Others
Table 9. Global Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 10. Global Nervous System Medications Sales Market Share by Type (2021-2026)
Table 11. Global Nervous System Medications Revenue by Type (2021-2026) & ($ million)
Table 12. Global Nervous System Medications Revenue Market Share by Type (2021-2026)
Table 13. Global Nervous System Medications Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Nervous System Medications Sale by Application (2021-2026) & (K Units)
Table 15. Global Nervous System Medications Sale Market Share by Application (2021-2026)
Table 16. Global Nervous System Medications Revenue by Application (2021-2026) & ($ million)
Table 17. Global Nervous System Medications Revenue Market Share by Application (2021-2026)
Table 18. Global Nervous System Medications Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Nervous System Medications Sales by Company (2021-2026) & (K Units)
Table 20. Global Nervous System Medications Sales Market Share by Company (2021-2026)
Table 21. Global Nervous System Medications Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Nervous System Medications Revenue Market Share by Company (2021-2026)
Table 23. Global Nervous System Medications Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Nervous System Medications Producing Area Distribution and Sales Area
Table 25. Players Nervous System Medications Products Offered
Table 26. Nervous System Medications Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Nervous System Medications Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Nervous System Medications Sales Market Share Geographic Region (2021-2026)
Table 31. Global Nervous System Medications Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Nervous System Medications Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Nervous System Medications Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Nervous System Medications Sales Market Share by Country/Region (2021-2026)
Table 35. Global Nervous System Medications Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Nervous System Medications Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Nervous System Medications Sales by Country (2021-2026) & (K Units)
Table 38. Americas Nervous System Medications Sales Market Share by Country (2021-2026)
Table 39. Americas Nervous System Medications Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 41. Americas Nervous System Medications Sales by Application (2021-2026) & (K Units)
Table 42. APAC Nervous System Medications Sales by Region (2021-2026) & (K Units)
Table 43. APAC Nervous System Medications Sales Market Share by Region (2021-2026)
Table 44. APAC Nervous System Medications Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 46. APAC Nervous System Medications Sales by Application (2021-2026) & (K Units)
Table 47. Europe Nervous System Medications Sales by Country (2021-2026) & (K Units)
Table 48. Europe Nervous System Medications Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 50. Europe Nervous System Medications Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Nervous System Medications Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Nervous System Medications Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Nervous System Medications Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Nervous System Medications
Table 56. Key Market Challenges & Risks of Nervous System Medications
Table 57. Key Industry Trends of Nervous System Medications
Table 58. Nervous System Medications Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Nervous System Medications Distributors List
Table 61. Nervous System Medications Customer List
Table 62. Global Nervous System Medications Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Nervous System Medications Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Nervous System Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Nervous System Medications Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Nervous System Medications Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Nervous System Medications Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Nervous System Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Nervous System Medications Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Nervous System Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Nervous System Medications Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Nervous System Medications Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Nervous System Medications Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Nervous System Medications Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Nervous System Medications Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Pfizer Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 77. Pfizer Nervous System Medications Product Portfolios and Specifications
Table 78. Pfizer Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Pfizer Main Business
Table 80. Pfizer Latest Developments
Table 81. Teva Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 82. Teva Nervous System Medications Product Portfolios and Specifications
Table 83. Teva Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Teva Main Business
Table 85. Teva Latest Developments
Table 86. Novartis Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 87. Novartis Nervous System Medications Product Portfolios and Specifications
Table 88. Novartis Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Novartis Main Business
Table 90. Novartis Latest Developments
Table 91. AstraZeneca Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 92. AstraZeneca Nervous System Medications Product Portfolios and Specifications
Table 93. AstraZeneca Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. AstraZeneca Main Business
Table 95. AstraZeneca Latest Developments
Table 96. Takeda Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 97. Takeda Nervous System Medications Product Portfolios and Specifications
Table 98. Takeda Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Takeda Main Business
Table 100. Takeda Latest Developments
Table 101. Johnson & Johnson Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Nervous System Medications Product Portfolios and Specifications
Table 103. Johnson & Johnson Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. EliLilly Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 107. EliLilly Nervous System Medications Product Portfolios and Specifications
Table 108. EliLilly Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. EliLilly Main Business
Table 110. EliLilly Latest Developments
Table 111. Otsuka Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 112. Otsuka Nervous System Medications Product Portfolios and Specifications
Table 113. Otsuka Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Otsuka Main Business
Table 115. Otsuka Latest Developments
Table 116. Merck Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 117. Merck Nervous System Medications Product Portfolios and Specifications
Table 118. Merck Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Merck Main Business
Table 120. Merck Latest Developments
Table 121. Yangtze River Pharmaceutical Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 122. Yangtze River Pharmaceutical Nervous System Medications Product Portfolios and Specifications
Table 123. Yangtze River Pharmaceutical Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Yangtze River Pharmaceutical Main Business
Table 125. Yangtze River Pharmaceutical Latest Developments
Table 126. Humanwell Healthcare Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 127. Humanwell Healthcare Nervous System Medications Product Portfolios and Specifications
Table 128. Humanwell Healthcare Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Humanwell Healthcare Main Business
Table 130. Humanwell Healthcare Latest Developments
Table 131. CSPC-NBP Pharmaceutical Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 132. CSPC-NBP Pharmaceutical Nervous System Medications Product Portfolios and Specifications
Table 133. CSPC-NBP Pharmaceutical Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. CSPC-NBP Pharmaceutical Main Business
Table 135. CSPC-NBP Pharmaceutical Latest Developments
Table 136. Nhwa Pharmaceutical Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 137. Nhwa Pharmaceutical Nervous System Medications Product Portfolios and Specifications
Table 138. Nhwa Pharmaceutical Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Nhwa Pharmaceutical Main Business
Table 140. Nhwa Pharmaceutical Latest Developments
Table 141. Qilu Pharma Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 142. Qilu Pharma Nervous System Medications Product Portfolios and Specifications
Table 143. Qilu Pharma Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Qilu Pharma Main Business
Table 145. Qilu Pharma Latest Developments
Table 1. Nervous System Medications Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nervous System Medications Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Anesthetic
Table 4. Major Players of Painkiller
Table 5. Major Players of Psychostimulants
Table 6. Major Players of Antiepileptic Drugs
Table 7. Major Players of Anti-Parkinson Drugs
Table 8. Major Players of Others
Table 9. Global Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 10. Global Nervous System Medications Sales Market Share by Type (2021-2026)
Table 11. Global Nervous System Medications Revenue by Type (2021-2026) & ($ million)
Table 12. Global Nervous System Medications Revenue Market Share by Type (2021-2026)
Table 13. Global Nervous System Medications Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Nervous System Medications Sale by Application (2021-2026) & (K Units)
Table 15. Global Nervous System Medications Sale Market Share by Application (2021-2026)
Table 16. Global Nervous System Medications Revenue by Application (2021-2026) & ($ million)
Table 17. Global Nervous System Medications Revenue Market Share by Application (2021-2026)
Table 18. Global Nervous System Medications Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Nervous System Medications Sales by Company (2021-2026) & (K Units)
Table 20. Global Nervous System Medications Sales Market Share by Company (2021-2026)
Table 21. Global Nervous System Medications Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Nervous System Medications Revenue Market Share by Company (2021-2026)
Table 23. Global Nervous System Medications Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Nervous System Medications Producing Area Distribution and Sales Area
Table 25. Players Nervous System Medications Products Offered
Table 26. Nervous System Medications Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Nervous System Medications Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Nervous System Medications Sales Market Share Geographic Region (2021-2026)
Table 31. Global Nervous System Medications Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Nervous System Medications Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Nervous System Medications Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Nervous System Medications Sales Market Share by Country/Region (2021-2026)
Table 35. Global Nervous System Medications Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Nervous System Medications Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Nervous System Medications Sales by Country (2021-2026) & (K Units)
Table 38. Americas Nervous System Medications Sales Market Share by Country (2021-2026)
Table 39. Americas Nervous System Medications Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 41. Americas Nervous System Medications Sales by Application (2021-2026) & (K Units)
Table 42. APAC Nervous System Medications Sales by Region (2021-2026) & (K Units)
Table 43. APAC Nervous System Medications Sales Market Share by Region (2021-2026)
Table 44. APAC Nervous System Medications Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 46. APAC Nervous System Medications Sales by Application (2021-2026) & (K Units)
Table 47. Europe Nervous System Medications Sales by Country (2021-2026) & (K Units)
Table 48. Europe Nervous System Medications Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 50. Europe Nervous System Medications Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Nervous System Medications Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Nervous System Medications Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Nervous System Medications Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Nervous System Medications Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Nervous System Medications
Table 56. Key Market Challenges & Risks of Nervous System Medications
Table 57. Key Industry Trends of Nervous System Medications
Table 58. Nervous System Medications Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Nervous System Medications Distributors List
Table 61. Nervous System Medications Customer List
Table 62. Global Nervous System Medications Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Nervous System Medications Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Nervous System Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Nervous System Medications Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Nervous System Medications Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Nervous System Medications Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Nervous System Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Nervous System Medications Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Nervous System Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Nervous System Medications Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Nervous System Medications Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Nervous System Medications Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Nervous System Medications Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Nervous System Medications Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Pfizer Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 77. Pfizer Nervous System Medications Product Portfolios and Specifications
Table 78. Pfizer Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Pfizer Main Business
Table 80. Pfizer Latest Developments
Table 81. Teva Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 82. Teva Nervous System Medications Product Portfolios and Specifications
Table 83. Teva Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Teva Main Business
Table 85. Teva Latest Developments
Table 86. Novartis Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 87. Novartis Nervous System Medications Product Portfolios and Specifications
Table 88. Novartis Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Novartis Main Business
Table 90. Novartis Latest Developments
Table 91. AstraZeneca Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 92. AstraZeneca Nervous System Medications Product Portfolios and Specifications
Table 93. AstraZeneca Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. AstraZeneca Main Business
Table 95. AstraZeneca Latest Developments
Table 96. Takeda Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 97. Takeda Nervous System Medications Product Portfolios and Specifications
Table 98. Takeda Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Takeda Main Business
Table 100. Takeda Latest Developments
Table 101. Johnson & Johnson Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Nervous System Medications Product Portfolios and Specifications
Table 103. Johnson & Johnson Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. EliLilly Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 107. EliLilly Nervous System Medications Product Portfolios and Specifications
Table 108. EliLilly Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. EliLilly Main Business
Table 110. EliLilly Latest Developments
Table 111. Otsuka Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 112. Otsuka Nervous System Medications Product Portfolios and Specifications
Table 113. Otsuka Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Otsuka Main Business
Table 115. Otsuka Latest Developments
Table 116. Merck Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 117. Merck Nervous System Medications Product Portfolios and Specifications
Table 118. Merck Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Merck Main Business
Table 120. Merck Latest Developments
Table 121. Yangtze River Pharmaceutical Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 122. Yangtze River Pharmaceutical Nervous System Medications Product Portfolios and Specifications
Table 123. Yangtze River Pharmaceutical Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Yangtze River Pharmaceutical Main Business
Table 125. Yangtze River Pharmaceutical Latest Developments
Table 126. Humanwell Healthcare Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 127. Humanwell Healthcare Nervous System Medications Product Portfolios and Specifications
Table 128. Humanwell Healthcare Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Humanwell Healthcare Main Business
Table 130. Humanwell Healthcare Latest Developments
Table 131. CSPC-NBP Pharmaceutical Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 132. CSPC-NBP Pharmaceutical Nervous System Medications Product Portfolios and Specifications
Table 133. CSPC-NBP Pharmaceutical Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. CSPC-NBP Pharmaceutical Main Business
Table 135. CSPC-NBP Pharmaceutical Latest Developments
Table 136. Nhwa Pharmaceutical Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 137. Nhwa Pharmaceutical Nervous System Medications Product Portfolios and Specifications
Table 138. Nhwa Pharmaceutical Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Nhwa Pharmaceutical Main Business
Table 140. Nhwa Pharmaceutical Latest Developments
Table 141. Qilu Pharma Basic Information, Nervous System Medications Manufacturing Base, Sales Area and Its Competitors
Table 142. Qilu Pharma Nervous System Medications Product Portfolios and Specifications
Table 143. Qilu Pharma Nervous System Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Qilu Pharma Main Business
Table 145. Qilu Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nervous System Medications
Figure 2. Nervous System Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nervous System Medications Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nervous System Medications Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nervous System Medications Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nervous System Medications Sales Market Share by Country/Region (2025)
Figure 10. Nervous System Medications Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Anesthetic
Figure 12. Product Picture of Painkiller
Figure 13. Product Picture of Psychostimulants
Figure 14. Product Picture of Antiepileptic Drugs
Figure 15. Product Picture of Anti-Parkinson Drugs
Figure 16. Product Picture of Others
Figure 17. Global Nervous System Medications Sales Market Share by Type in 2026
Figure 18. Global Nervous System Medications Revenue Market Share by Type (2021-2026)
Figure 19. Nervous System Medications Consumed in Hospital Pharmacy
Figure 20. Global Nervous System Medications Market: Hospital Pharmacy (2021-2026) & (K Units)
Figure 21. Nervous System Medications Consumed in Retail Pharmacy
Figure 22. Global Nervous System Medications Market: Retail Pharmacy (2021-2026) & (K Units)
Figure 23. Nervous System Medications Consumed in Online Pharmacy
Figure 24. Global Nervous System Medications Market: Online Pharmacy (2021-2026) & (K Units)
Figure 25. Global Nervous System Medications Sale Market Share by Application (2025)
Figure 26. Global Nervous System Medications Revenue Market Share by Application in 2026
Figure 27. Nervous System Medications Sales by Company in 2026 (K Units)
Figure 28. Global Nervous System Medications Sales Market Share by Company in 2026
Figure 29. Nervous System Medications Revenue by Company in 2026 ($ millions)
Figure 30. Global Nervous System Medications Revenue Market Share by Company in 2026
Figure 31. Global Nervous System Medications Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Nervous System Medications Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Nervous System Medications Sales 2021-2026 (K Units)
Figure 34. Americas Nervous System Medications Revenue 2021-2026 ($ millions)
Figure 35. APAC Nervous System Medications Sales 2021-2026 (K Units)
Figure 36. APAC Nervous System Medications Revenue 2021-2026 ($ millions)
Figure 37. Europe Nervous System Medications Sales 2021-2026 (K Units)
Figure 38. Europe Nervous System Medications Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Nervous System Medications Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Nervous System Medications Revenue 2021-2026 ($ millions)
Figure 41. Americas Nervous System Medications Sales Market Share by Country in 2026
Figure 42. Americas Nervous System Medications Revenue Market Share by Country (2021-2026)
Figure 43. Americas Nervous System Medications Sales Market Share by Type (2021-2026)
Figure 44. Americas Nervous System Medications Sales Market Share by Application (2021-2026)
Figure 45. United States Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Nervous System Medications Sales Market Share by Region in 2026
Figure 50. APAC Nervous System Medications Revenue Market Share by Region (2021-2026)
Figure 51. APAC Nervous System Medications Sales Market Share by Type (2021-2026)
Figure 52. APAC Nervous System Medications Sales Market Share by Application (2021-2026)
Figure 53. China Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 57. India Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Nervous System Medications Sales Market Share by Country in 2026
Figure 61. Europe Nervous System Medications Revenue Market Share by Country (2021-2026)
Figure 62. Europe Nervous System Medications Sales Market Share by Type (2021-2026)
Figure 63. Europe Nervous System Medications Sales Market Share by Application (2021-2026)
Figure 64. Germany Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 65. France Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Nervous System Medications Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Nervous System Medications Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Nervous System Medications Sales Market Share by Application (2021-2026)
Figure 72. Egypt Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Nervous System Medications in 2026
Figure 78. Manufacturing Process Analysis of Nervous System Medications
Figure 79. Industry Chain Structure of Nervous System Medications
Figure 80. Channels of Distribution
Figure 81. Global Nervous System Medications Sales Market Forecast by Region (2027-2032)
Figure 82. Global Nervous System Medications Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Nervous System Medications Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Nervous System Medications Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Nervous System Medications Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Nervous System Medications Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Nervous System Medications
Figure 2. Nervous System Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nervous System Medications Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nervous System Medications Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nervous System Medications Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nervous System Medications Sales Market Share by Country/Region (2025)
Figure 10. Nervous System Medications Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Anesthetic
Figure 12. Product Picture of Painkiller
Figure 13. Product Picture of Psychostimulants
Figure 14. Product Picture of Antiepileptic Drugs
Figure 15. Product Picture of Anti-Parkinson Drugs
Figure 16. Product Picture of Others
Figure 17. Global Nervous System Medications Sales Market Share by Type in 2026
Figure 18. Global Nervous System Medications Revenue Market Share by Type (2021-2026)
Figure 19. Nervous System Medications Consumed in Hospital Pharmacy
Figure 20. Global Nervous System Medications Market: Hospital Pharmacy (2021-2026) & (K Units)
Figure 21. Nervous System Medications Consumed in Retail Pharmacy
Figure 22. Global Nervous System Medications Market: Retail Pharmacy (2021-2026) & (K Units)
Figure 23. Nervous System Medications Consumed in Online Pharmacy
Figure 24. Global Nervous System Medications Market: Online Pharmacy (2021-2026) & (K Units)
Figure 25. Global Nervous System Medications Sale Market Share by Application (2025)
Figure 26. Global Nervous System Medications Revenue Market Share by Application in 2026
Figure 27. Nervous System Medications Sales by Company in 2026 (K Units)
Figure 28. Global Nervous System Medications Sales Market Share by Company in 2026
Figure 29. Nervous System Medications Revenue by Company in 2026 ($ millions)
Figure 30. Global Nervous System Medications Revenue Market Share by Company in 2026
Figure 31. Global Nervous System Medications Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Nervous System Medications Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Nervous System Medications Sales 2021-2026 (K Units)
Figure 34. Americas Nervous System Medications Revenue 2021-2026 ($ millions)
Figure 35. APAC Nervous System Medications Sales 2021-2026 (K Units)
Figure 36. APAC Nervous System Medications Revenue 2021-2026 ($ millions)
Figure 37. Europe Nervous System Medications Sales 2021-2026 (K Units)
Figure 38. Europe Nervous System Medications Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Nervous System Medications Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Nervous System Medications Revenue 2021-2026 ($ millions)
Figure 41. Americas Nervous System Medications Sales Market Share by Country in 2026
Figure 42. Americas Nervous System Medications Revenue Market Share by Country (2021-2026)
Figure 43. Americas Nervous System Medications Sales Market Share by Type (2021-2026)
Figure 44. Americas Nervous System Medications Sales Market Share by Application (2021-2026)
Figure 45. United States Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Nervous System Medications Sales Market Share by Region in 2026
Figure 50. APAC Nervous System Medications Revenue Market Share by Region (2021-2026)
Figure 51. APAC Nervous System Medications Sales Market Share by Type (2021-2026)
Figure 52. APAC Nervous System Medications Sales Market Share by Application (2021-2026)
Figure 53. China Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 57. India Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Nervous System Medications Sales Market Share by Country in 2026
Figure 61. Europe Nervous System Medications Revenue Market Share by Country (2021-2026)
Figure 62. Europe Nervous System Medications Sales Market Share by Type (2021-2026)
Figure 63. Europe Nervous System Medications Sales Market Share by Application (2021-2026)
Figure 64. Germany Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 65. France Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Nervous System Medications Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Nervous System Medications Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Nervous System Medications Sales Market Share by Application (2021-2026)
Figure 72. Egypt Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Nervous System Medications Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Nervous System Medications in 2026
Figure 78. Manufacturing Process Analysis of Nervous System Medications
Figure 79. Industry Chain Structure of Nervous System Medications
Figure 80. Channels of Distribution
Figure 81. Global Nervous System Medications Sales Market Forecast by Region (2027-2032)
Figure 82. Global Nervous System Medications Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Nervous System Medications Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Nervous System Medications Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Nervous System Medications Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Nervous System Medications Revenue Market Share Forecast by Application (2027-2032)
